From Bench to Bedside: Is Lung Transplant Ready for dd-cfDNA Revolution?
Published 16 July 2025
At their industry symposium at ISHLT2025, CareDx, Inc. reviewed extended applications of molecular testing through clinical scenarios and diverse patient populations. Leaders in pulmonology shared new data from multi-modality testing in lung transplant recipients and showcased the latest data from one of the largest registries of molecular testing in lung transplant.
Through the support of CareDx, Inc., this session is now available for you to view on demand.
The content of this recording was developed entirely by our industry partner, CareDx, Inc. It is not an official educational program of the ISHLT, and therefore is not eligible for CME under the ISHLT.